QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=88B502D56E71E86F369884676DE917D3;jsessionid=2862C79042FBC9B36A81A997DA7667F1;jsessionid=6DF76FFF9265753D11324C04514FE837;jsessionid=C94E7631FB732ADEDAD1B7CCF16DD6D3;jsessionid=CEA83979609780B0030E11E1B8C667F2;jsessionid=855F72207E4BD666B54312B53ACFBF86 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=88B502D56E71E86F369884676DE917D3;jsessionid=2862C79042FBC9B36A81A997DA7667F1;jsessionid=6DF76FFF9265753D11324C04514FE837;jsessionid=C94E7631FB732ADEDAD1B7CCF16DD6D3;jsessionid=CEA83979609780B0030E11E1B8C667F2;jsessionid=855F72207E4BD666B54312B53ACFBF86